Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
PL02.03 Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
2021
28 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
2.14
PL02.03 Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial | Researchclopedia
·
The Netherlands Cancer Institute
Alberto Chiappori
·
Moffitt Cancer Center
M.E. Olmedo
·
Hospital Universitario Ramón y Cajal
Ildikó Horváth
·
Országos Korányi Tbc és Pulmonológiai Intézet
Christian Grohé
·
Evangelische Lungenklinik Berlin
José Antonio López-Vilariño
·
PharmaMar (Spain)
Ramiro Manzano-Núñez
·
PharmaMar (Spain)
Antonio Nieto
·
PharmaMar (Spain)
M. Cullell
·
PharmaMar (Spain)
Nuno Vasco
·
PharmaMar (Spain)
Carmen Kahatt
·
PharmaMar (Spain)
Ali Zeaiter
·
PharmaMar (Spain)
Enric Carcereny
·
Institut Català d'Oncologia
Jaromı́r Roubec
·
Vítkovická Nemocnice
K. Syrigos
·
National and Kapodistrian University of Athens
Gregory Lo
I. Barneto
·
Hospital Universitario Reina Sofía